MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-TS-02-0023227
Aurex Laboratories Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹48,503
▲ 5% YoY
Net loss · FY 2025
₹1.59 Cr
Latest filing
EBITDA · FY 2025
-₹1.59 Cr
Latest filing
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
11 yrs
Est. 2015
Directors on board
2
As per MCA filings
GST registrations
2
None active
About Aurex Laboratories Private Limited
Data last updated:
Aurex Laboratories Private Limited is a private limited company based in Hyderabad, Telangana, India, a subsidiary of Ez Minds I.T Solutions Private Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 11 August 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24240TG2015PTC100187. The company has 2 GST registrations on record, none of which is active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Kanchana Durga Arvapally and Varun Aravapalli.
Its last annual general meeting (AGM) was held on 27 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 5 – 35/189/A Survey No. 390 Ist Floor Type III Industrial Estate Kukatpally, Hyderabad, Telangana, India – 500072.
As per the financials filed for FY 2025, the company reported a revenue of ₹48,503, a growth of 5% compared to the previous year. For the same year it recorded a net loss of ₹1.59 Cr and EBITDA of -₹1.59 Cr. Revenue has declined at a compounded annual rate (CAGR) of 79% over three years and 66% over five years.
The company is associated with 1 brand: Aurex Laboratories. Court records list 1 case involving the company, including 1 filed against it.
Aurex Laboratories Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0023227). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website aurexlabs.com.
Company details
CIN U24240TG2015PTC100187
Registration Number 100187
Incorporation Date 11 August 2015
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 27 September 2024
Date of Balance Sheet 31 March 2024
Parent Company Ez Minds I.T Solutions Private Limited
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-TS-02-0023227
Recognitions & Rankings of Aurex Laboratories
Contact details
Aurex Laboratories Private Limited's registered office is in Hyderabad, Telangana. Its website is aurexlabs.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address5 – 35/189/A Survey No. 390 Ist Floor Type III Industrial Estate Kukatpally, Hyderabad, Telangana, India – 500072
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Aurex Laboratories Private Limited, buy the company report.
Comprehensive company report
Aurex Laboratories Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Aurex Laboratories operates one associated brand: Aurex Laboratories. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Drug manufacturing for multiple therapeutic areas is conducted through R&D. | aurexlabs.com |
Financials of Aurex Laboratories Private Limited
FY 2024 filings availableAurex Laboratories Private Limited reported revenue of ₹48,503 (up 5% YoY) for FY 2025.
Revenue · FY 2025
₹48,503 ▲ 5%
Net loss · FY 2025
₹1.59 Cr
EBITDA · FY 2025
-₹1.59 Cr
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 5%
3 years · compounded
▼ 79%
5 years · compounded
▼ 66%
EBITDA CAGR growth
1 year
▼ 7%
3 years · compounded
▼ 42%
5 years · compounded
▼ 42%
Revenue rose 5% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 66%. EBITDA fell 7% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹1.59 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1.59 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Aurex Laboratories Private Limited, buy the company report.
Board of directors of Aurex Laboratories Private Limited
Aurex Laboratories has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kanchana Durga Arvapally | Director | 11 Aug 2015 | 11 Years 2 Months | Current |
| Varun Aravapalli | Director | 24 Dec 2021 | 4 Years 9 Months | Current |
Peer comparison
Aurex Laboratories Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Astrozen Pharmaceuticals Private Limited | ₹49,914 (FY 2022) | 15.0% | Thane, Maharashtra, India | |||
| Nectar Lifestyles Private Limited | ₹48,570 (FY 2018) | New Delhi, Delhi, India | ||||
| Aurex Laboratories Private Limitedthis company | ₹48,503 (FY 2025) | -₹1.59 Cr | 5.0% | Hyderabad, Telangana, India | ||
| Femera Life Sciences and Healthcare Private Limited | ₹47,832 (FY 2025) | -93.0% | Pune, Maharashtra, India |
To see the full peer comparison of Aurex Laboratories Private Limited, buy the company report.
Auditor
Aurex Laboratories Private Limited is audited by MOMCHURIANDASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MOMCHURIANDASSOCIATES | FY 2023 | 010730S |
Shareholding
The shareholding of Aurex Laboratories Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Aurex Laboratories Private Limited, buy the company report.
Legal cases
Aurex Laboratories Private Limited has 1 court case on record: 1 filed against it. All case is disposed.
Total cases
1
Filed against the company
1
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, GUJARAT | Court case (IAAP) | Filed against the company by M/S Cliantha Research Limited | Disposed |
To see the full case history of Aurex Laboratories Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Aurex Laboratories Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Aurex Laboratories has 2 GST registrations on record, and all of them have been cancelled or are inactive. Only active GST numbers are listed on this page.
Total GSTINs
2
Cancelled / inactive
2
To see the full GST registrations and return filing status of Aurex Laboratories Private Limited, buy the company report.
Recent activity
Aurex Laboratories Private Limited has 4 board changes on record since 2015: 2 appointments and 2 cessations. The latest: Varun Aravapalli ceased to be Additional Director on 28 Sep 2023.
AGM
Aurex Laboratories Private Limited last Annual general meeting of members was held on 27 Sep 2024 as per latest MCA records.
Filing
Aurex Laboratories Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
Ceased
Varun Aravapalli ceased to be Additional Director.
Appointed
Varun Aravapalli was appointed as Director.
Ceased
Sree Ranganayakulu Aravapalli ceased to be Director.
Appointed
Kanchana Durga Arvapally was appointed as Director.
Incorporation
11 Aug 2015
Aurex Laboratories Private Limited was registered on 11 Aug 2015 with Roc Hyderabad & aged 11 years 2 months as per MCA records.
Frequently asked questions
Aurex Laboratories is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 11 August 2015 (11+ years old) and is registered under CIN U24240TG2015PTC100187.
Aurex Laboratories has 2 current directors:
- Kanchana Durga Arvapally - Director
- Varun Aravapalli - Director
The latest financial statements of Aurex Laboratories on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 27 September 2024. Year-wise statements from FY 2016 are in the company report.
No. Aurex Laboratories has 2 GST registrations on record and all of them are cancelled or inactive.
The CIN (Corporate Identification Number) of Aurex Laboratories is U24240TG2015PTC100187. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aurex Laboratories has 1 court case on record: 1 filed against it.
Aurex Laboratories was incorporated on 11 August 2015, making it 11+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Aurex Laboratories by revenue are Astrozen Pharmaceuticals Private Limited, Nectar Lifestyles Private Limited, Femera Life Sciences and Healthcare Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Varun Aravapalli ceased to be Additional Director on 28 Sep 2023. Varun Aravapalli was appointed as Director on 24 Dec 2021. Sree Ranganayakulu Aravapalli ceased to be Director on 26 Oct 2021. Aurex Laboratories has 4 board changes on record in total.
Yes, Aurex Laboratories is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-02-0023227).
Aurex Laboratories can be reached through the website aurexlabs.com. Its registered office is in Hyderabad, Telangana, India.